New insights into cardiovascular and lipid metabolomics
暂无分享,去创建一个
[1] R. Kronmal,et al. Cholesteryl ester transfer protein genetic polymorphisms, HDL cholesterol, and subclinical cardiovascular disease in the Multi-Ethnic Study of Atherosclerosis. , 2008, Atherosclerosis.
[2] G. Bray,et al. Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity , 2008, Expert review of cardiovascular therapy.
[3] B. Astor,et al. Mild elevations of urine albumin excretion are associated with atherogenic lipoprotein abnormalities in the Multi-Ethnic Study of Atherosclerosis (MESA). , 2008, Atherosclerosis.
[4] Claudio Napoli,et al. Proteomics and cardiovascular disease: an update. , 2008, Current medicinal chemistry.
[5] M. Korbonits,et al. The role of AMP-activated protein kinase in obesity. , 2008, Frontiers of hormone research.
[6] N. Veljkovic,et al. Lipoprotein lipase: A bioinformatics criterion for assessment of mutations as a risk factor for cardiovascular disease , 2008, Proteins.
[7] Robert A. Harris,et al. Overexpression of pyruvate dehydrogenase kinase 4 in heart perturbs metabolism and exacerbates calcineurin-induced cardiomyopathy. , 2008, American journal of physiology. Heart and circulatory physiology.
[8] P. Ridker,et al. A kinesin family member 6 variant is associated with coronary heart disease in the Women's Health Study. , 2008, Journal of the American College of Cardiology.
[9] Marc A Pfeffer,et al. Association of the Trp719Arg polymorphism in kinesin-like protein 6 with myocardial infarction and coronary heart disease in 2 prospective trials: the CARE and WOSCOPS trials. , 2008, Journal of the American College of Cardiology.
[10] M. Sabatine,et al. Polymorphism in KIF6 gene and benefit from statins after acute coronary syndromes: results from the PROVE IT-TIMI 22 study. , 2008, Journal of the American College of Cardiology.
[11] Miron Livny,et al. BioMagResBank , 2007, Nucleic Acids Res..
[12] Tomoyoshi Soga,et al. Metabolome analysis by capillary electrophoresis-mass spectrometry. , 2007, Journal of chromatography. A.
[13] Michelle L. Reyzer,et al. MALDI imaging mass spectrometry: molecular snapshots of biochemical systems , 2007, Nature Methods.
[14] Xianlin Han,et al. Shotgun metabolomics approach for the analysis of negatively charged water-soluble cellular metabolites from mouse heart tissue. , 2007, Analytical chemistry.
[15] R. Caprioli,et al. Profiling and imaging of tissues by imaging ion mobility-mass spectrometry. , 2007, Journal of mass spectrometry : JMS.
[16] Kazuki Saito,et al. Application of a metabolomic method combining one-dimensional and two-dimensional gas chromatography-time-of-flight/mass spectrometry to metabolic phenotyping of natural variants in rice. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[17] A. Woods,et al. MALDI-ion mobility-TOFMS imaging of lipids in rat brain tissue. , 2007, Journal of mass spectrometry : JMS.
[18] M. Orešič,et al. Data processing for mass spectrometry-based metabolomics. , 2007, Journal of chromatography. A.
[19] R. Goodacre,et al. Quantitative detection of metabolites using matrix-assisted laser desorption/ionization mass spectrometry with 9-aminoacridine as the matrix. , 2007, Rapid communications in mass spectrometry : RCM.
[20] E. K. Kemsley,et al. Multivariate techniques and their application in nutrition: a metabolomics case study , 2007, British Journal of Nutrition.
[21] A. Smilde,et al. Assessing the statistical validity of proteomics based biomarkers. , 2007, Analytica chimica acta.
[22] Xianlin Han,et al. Alterations in myocardial cardiolipin content and composition occur at the very earliest stages of diabetes: a shotgun lipidomics study. , 2007, Biochemistry.
[23] Joseph L. Cantone,et al. Utility of imaging mass spectrometry (IMS) by matrix-assisted laser desorption ionization (MALDI) on an ion trap mass spectrometer in the analysis of drugs and metabolites in biological tissues. , 2007, Journal of pharmacological and toxicological methods.
[24] R. Cox,et al. A metabolomic comparison of urinary changes in type 2 diabetes in mouse, rat, and human. , 2007, Physiological genomics.
[25] P. Libby,et al. Atherosclerosis: the path from genomics to therapeutics. , 2007, Journal of the American College of Cardiology.
[26] Oliver Fiehn,et al. A comprehensive urinary metabolomic approach for identifying kidney cancerr. , 2007, Analytical biochemistry.
[27] David S Wishart,et al. Computational systems biology in drug discovery and development: methods and applications. , 2007, Drug discovery today.
[28] J. van der Greef,et al. The art and practice of systems biology in medicine: mapping patterns of relationships. , 2007, Journal of proteome research.
[29] A. Tsantili-Kakoulidou,et al. Application of NMR-based metabonomics in the investigation of myocardial ischemia-reperfusion, ischemic preconditioning and antioxidant intervention in rabbits. , 2007, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[30] J. German,et al. Lipidomics and lipid profiling in metabolomics , 2007, Current opinion in lipidology.
[31] Michelle L. Reyzer,et al. MALDI-MS-based imaging of small molecules and proteins in tissues. , 2007, Current Opinion in Chemical Biology.
[32] Mark P. Styczynski,et al. Systematic identification of conserved metabolites in GC/MS data for metabolomics and biomarker discovery. , 2007, Analytical chemistry.
[33] G. Siuzdak,et al. From exogenous to endogenous: the inevitable imprint of mass spectrometry in metabolomics. , 2007, Journal of proteome research.
[34] A. Tsantili-Kakoulidou,et al. 1H NMR monitoring of the canine metabolic profile after oral administration of xenobiotics using multivariate statistics. , 2007, Molecular pharmaceutics.
[35] Ying Zhang,et al. HMDB: the Human Metabolome Database , 2007, Nucleic Acids Res..
[36] Jing Li,et al. New Bioinformatics Resources For Metabolomics , 2006, Pacific Symposium on Biocomputing.
[37] R. Kaddurah-Daouk,et al. High-Performance Liquid Chromatography Separations Coupled With Coulometric Electrode Array Detectors , 2007 .
[38] R. Kaddurah-Daouk,et al. High-performance liquid chromatography separations coupled with coulometric electrode array detectors: a unique approach to metabolomics. , 2007, Methods in molecular biology.
[39] D. Ford,et al. Myocardial lipidomics. Developments in myocardial nuclear lipidomics. , 2007, Frontiers in bioscience : a journal and virtual library.
[40] Daniel Raftery,et al. Comparing and combining NMR spectroscopy and mass spectrometry in metabolomics , 2007, Analytical and bioanalytical chemistry.
[41] Tomoyoshi Soga,et al. Capillary electrophoresis-mass spectrometry for metabolomics. , 2007, Methods in molecular biology.
[42] D. Dix,et al. The ToxCast program for prioritizing toxicity testing of environmental chemicals. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.
[43] Julian L Griffin,et al. Metabolomics as a functional genomic tool for understanding lipid dysfunction in diabetes, obesity and related disorders. , 2006, Pharmacogenomics.
[44] A. Watson,et al. Thematic Review Lipidomics: a Global Approach to Lipid Analysis in Biological Systems , 2022 .
[45] Aldons J. Lusis,et al. A thematic review series: systems biology approaches to metabolic and cardiovascular disorders , 2006, Journal of Lipid Research.
[46] M. Walsh,et al. Effect of acute dietary standardization on the urinary, plasma, and salivary metabolomic profiles of healthy humans. , 2006, The American journal of clinical nutrition.
[47] Nigel W. Hardy,et al. Establishing reporting standards for metabolomic and metabonomic studies: a call for participation. , 2006, Omics : a journal of integrative biology.
[48] L. Mueller,et al. Metabolomic analysis using optimized NMR and statistical methods. , 2006, Analytical biochemistry.
[49] Harald Schwalbe,et al. Biomolecular NMR: a chaperone to drug discovery , 2006, Current Opinion in Chemical Biology.
[50] L. Summers. Adipose tissue metabolism, diabetes and vascular disease — lessons from in vivo studies , 2006, Diabetes & vascular disease research.
[51] Frederick P Roth,et al. Metabolomic Identification of Novel Biomarkers of Myocardial Ischemia , 2005, Circulation.
[52] Xianlin Han,et al. Shotgun lipidomics identifies cardiolipin depletion in diabetic myocardium linking altered substrate utilization with mitochondrial dysfunction. , 2005, Biochemistry.
[53] S. Gatzek,et al. Controlled protein precipitation in combination with chip-based nanospray infusion mass spectrometry. An approach for metabolomics profiling of plasma. , 2005, Analytical chemistry.
[54] Xianlin Han,et al. Shotgun lipidomics: electrospray ionization mass spectrometric analysis and quantitation of cellular lipidomes directly from crude extracts of biological samples. , 2005, Mass spectrometry reviews.
[55] Ronald J. Moore,et al. Automated 20 kpsi RPLC-MS and MS/MS with chromatographic peak capacities of 1000-1500 and capabilities in proteomics and metabolomics. , 2005, Analytical chemistry.
[56] Xianlin Han,et al. Shotgun lipidomics: multidimensional MS analysis of cellular lipidomes , 2005, Expert review of proteomics.
[57] Joachim Kopka,et al. Metabolome analysis: the potential of in vivo labeling with stable isotopes for metabolite profiling. , 2005, Trends in biotechnology.
[58] A. Tsantili-Kakoulidou,et al. Melatonin does not prevent the protection of ischemic preconditioning in vivo despite its antioxidant effect against oxidative stress. , 2004, Free radical biology & medicine.
[59] W. Weckwerth. Metabolomics in systems biology. , 2003, Annual review of plant biology.
[60] V. Monnier,et al. Vitamin C metabolomic mapping in experimental diabetes with 6-deoxy-6-fluoro-ascorbic acid and high resolution 19F-nuclear magnetic resonance spectroscopy. , 2003, Metabolism: clinical and experimental.
[61] J. Nicholson,et al. Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics , 2002, Nature Medicine.
[62] Xianlin Han,et al. Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease: potential role in disease pathogenesis , 2002, Journal of neurochemistry.
[63] C. Napoli,et al. Effect of glycaemic control and age on low-density lipoprotein susceptibility to oxidation in diabetes mellitus type 1. , 2001, European heart journal.
[64] Xianlin Han,et al. Plasmalogen deficiency in early Alzheimer's disease subjects and in animal models: molecular characterization using electrospray ionization mass spectrometry , 2001, Journal of neurochemistry.
[65] R. Gross,et al. Diabetes-induced changes in specific lipid molecular species in rat myocardium. , 2000, The Biochemical journal.